Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues | SpringerLink
Biomarkers for the diagnosis and management of heart failure | SpringerLink
Kardiální markery
OLM (cs) K 1.7. budou převedeny kardiální markery
Biomarkers in Routine Heart Failure Clinical Care
Untitled
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research
A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio - ScienceDirect
Cardiac Markers-cTnI/cTnT/ NT-proBNP/MYO/D-Dimer | Fapon Biotech Inc.
Cardiac Biomarkers | Clinician's Brief
N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease | Scientific Reports
High-level production of N-terminal pro-brain natriuretic peptide, as a calibrant of heart failure diagnosis, in Escherichia coli | SpringerLink
Kardiomarkery (učební text): Srdeční selhání
Troponiny - ManaCon
Biomarkers in Advanced Heart Failure | Circulation: Heart Failure
Kardiální markery
Frontiers | Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Cyklus: KM2/19 – Kardiální markery
Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik
Rapid cardiovascular disease test - RAMP® NT-proBNP - Response Biomedical Corporation - BNP / blood / immunochromatographic
NT-proBNP FIA (20 testů) | LAB MARK
BNP und NT-proBNP: Zwei kardiale Marker werden „erwachsen“
Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide | Biomarkers in Medicine
Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. - Abstract - Europe PMC
